Pharmafile Logo

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell, 2020). A 2023 study calculated that these financial losses can reach approximately $500,000 in lost drug sales and $40,000 in direct clinical trial costs per day of delay (appliedclinicaltrialsonline.com), so the sites chosen to participate in the trial and the support provided to them during patient recruitment can be one of the major deciding factors between an on-time trial and a delayed, over-budget trial.

- PMLiVE

🔍 Is Your Influenza Clinical Trial Ready for the Upcoming Flu Season? 🩺
The clock is ticking—flu season is just around the corner! With 86% of clinical trials failing to meet recruitment goals, it’s crucial that your sites are fully prepared to recruit patients effectively.

Our latest blog explores key strategies to enhance site motivation, streamline recruitment processes, and overcome common challenges in patient recruitment. Don’t let delays cost you—read Part #2 of our series to ensure your trial is on track for success this flu season.

🚀 Read the full blog and boost your recruitment strategy today! 👉 https://bit.ly/4cFG7ql

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Innovative Trials’ CEO wins Women in Pharma Award

Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, won the ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was...

Innovative Trials nominated finalist at the Pharma Industry Award

Patient recruitment company, Innovative Trials, has been nominated as a finalist in 2 categories at the Pharma Industry Award Read the full press release 👉🏽 https://bit.ly/3MdzBwf

Patient Recruitment & Retention Webinar for Influenza Studies

Join the upcoming webinar which will discuss key patient recruitment & retention challenges and solutions for upcoming influenza studies.

[Free Whitepaper] 6 reasons why direct patient support is a ‘must have’ for your clinical trials

This white paper explores the importance of patient-first services and why direct patient support is crucial for the success of sponsors’ clinical trials. Download it for FREE 👉🏽  https://innovativetrials.com/six-reasons-why-direct-patient-support-is-a-must-have-for-your-clinical-trials/ 

Uniting Communities for Rare Disease Clinical Trial Success

Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, "Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success." Delve deep into...

Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape

In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to...

Solving your biggest patient recruitment and retention challenges

Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to...

Innovative Trials Announces New Charity Partnerships

Innovative Trials, a global patient recruitment and retention company, has just announced GOSH Charity and Oliver Patch Project as their charity partners of the year

Free Live Webinar – Uniting Communities for Rare Disease Clinical Trial Success

Join this live webinar focusing on patient recruitment and retention in rare disease trials.

Retention Patch Program

A partnership between Innovative Trials and the non-profit Oliver Patch Project to boost retention in pediatric studies